
What Happens when People with Dementia Commit Crimes?
When criminal behavior overlaps with degenerative cognitive disease, the justice system often falters
Jessica Wapner is a science journalist. She is author of Wall Disease (2020) and The Philadelphia Chromosome (2014), both published by The Experiment. Wapner lives in upstate New York. Credit: Nick Higgins
When criminal behavior overlaps with degenerative cognitive disease, the justice system often falters
Stanford neurobiologist Andrew Huberman discusses the two things we can always control, even during a high-stress election and scary COVID pandemic
Despite progress, genetic profiling of tumors has a long way to go
It can be performed at a clinic, yield same-day results and may cost less than half the current test
Counterintuitively, key heart health indicators proved markedly better in dogs with pacemakers programmed for a period of irregular contractions
New software and gene analyses may predict which medicines can become harmful when taken together
Large study reveals adolescents from low-income families have more physical and psychological issues
For many liver disease patients, implantation of a few new cells from a healthy organ may buy time or avoid a full transplant altogether
A long, difficult and costly research effort gives doctors a new cure for hepatitis C
A new book tells the tale of Gleevec, a breakthrough treatment that targets cancer at the genetic level
Many hospitals fail to take simple measures to prevent infections of a new strain of Clostridium difficile that's hard to track and at least in part responsible for skyrocketing infection rates in U.S...
The biomedical evidence for alternative or complementary treatments for cancer, beyond acupuncture, remains thin, although it probably didn't harm Jobs
A giant magnet is illuminating how the influenza A virus mutates to resist drugs
Long-awaited breakthroughs in developing preclinical animal models are signaling a new era for liver-targeted viruses and beyond
The Orphan Drug Act has stimulated research and produced blockbusters like Botox, but interest may be waning
With medical applications for smart phones becoming a more prominent part of doctors' diagnostic tool kits, the FDA is considering how it should regulate the market--if at all
State-legislated programs for the donation of unused drugs have seen limited success
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account